These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19233502)

  • 1. Who should get a liver graft?
    Clavien PA
    J Hepatol; 2009 Apr; 50(4):662-3. PubMed ID: 19233502
    [No Abstract]   [Full Text] [Related]  

  • 2. Who should get a liver graft?
    Freeman RB; Jamieson N; Schaubel DE; Porte RJ; Villamil FG
    J Hepatol; 2009 Apr; 50(4):664-73. PubMed ID: 19233503
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
    Adler M; De Pauw F; Vereerstraeten P; Fancello A; Lerut J; Starkel P; Van Vlierberghe H; Troisi R; Donckier V; Detry O; Delwaide J; Michielsen P; Chapelle T; Pirenne J; Nevens F
    Liver Transpl; 2008 Apr; 14(4):526-33. PubMed ID: 18383082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining disparities in liver transplantation: The devil is in the details.
    Goldberg DS
    Liver Transpl; 2016 Dec; 22(12):1720-1723. PubMed ID: 27786407
    [No Abstract]   [Full Text] [Related]  

  • 5. Should liver transplantation be made available to everyone? The case against.
    Neuberger J
    Arch Intern Med; 2003 Sep; 163(16):1881-3; discussion 1885-6. PubMed ID: 12963557
    [No Abstract]   [Full Text] [Related]  

  • 6. Model for end-stage liver disease exceptions: proceed with caution.
    Washburn K
    Liver Transpl; 2011 Oct; 17(10):1123-4. PubMed ID: 21837739
    [No Abstract]   [Full Text] [Related]  

  • 7. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.
    Wald C; Russo MW; Heimbach JK; Hussain HK; Pomfret EA; Bruix J
    Radiology; 2013 Feb; 266(2):376-82. PubMed ID: 23362092
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver allocation for patients with hepatocellular carcinoma.
    Neuberger J
    Liver Transpl; 2010 Mar; 16(3):249-51. PubMed ID: 20209584
    [No Abstract]   [Full Text] [Related]  

  • 9. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in the era of model for end-stage liver disease.
    Wang VS; Saab S
    Liver Int; 2004 Feb; 24(1):1-8. PubMed ID: 15101994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Survival benefit": the final destination, with still a long way to go.
    Piscaglia F; Cucchetti A; Bolondi L
    Dig Liver Dis; 2010 Sep; 42(9):608-10. PubMed ID: 20678743
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liver transplantation - current aspects of allocation, indication and donor pool expansion].
    Settmacher U; Scheuerlein H; Dittmar Y; Rauchfuss F
    Zentralbl Chir; 2013 Dec; 138(6):604-10. PubMed ID: 23238834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate selection and organ allocation in liver transplantation.
    Dawwas MF; Gimson AE
    Semin Liver Dis; 2009 Feb; 29(1):40-52. PubMed ID: 19235658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Dupuis-Lozeron E; Majno P; Berney T; Kneteman NM; Perneger T; Morel P; Mentha G; Combescure C
    Hepatology; 2012 Jul; 56(1):149-56. PubMed ID: 22271250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response.
    Wald C; Russo MW; Heimbach JK; Hussain HK; Pomfret EA; Bruix J
    Radiology; 2013 Nov; 269(2):619-20. PubMed ID: 24312935
    [No Abstract]   [Full Text] [Related]  

  • 16. [The MELD system and organ allocation policy: lessons after the first year of use in the United States].
    Tome S; Botero RC; Lucey MR
    Gastroenterol Hepatol; 2004 Jan; 27(1):35-40. PubMed ID: 14718108
    [No Abstract]   [Full Text] [Related]  

  • 17. The difference and the transition of indication for adult living donor liver transplantation between the West and the East.
    Bo WT; Yan LN
    Transplant Proc; 2008 Dec; 40(10):3507-11. PubMed ID: 19100425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfair priority for HCC: A problem whose ideal solution remains unsolved.
    Volk ML
    Am J Transplant; 2010 Jul; 10(7):1507-8. PubMed ID: 20642675
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality risk, behavior, and pediatric liver allocation.
    Freeman RB
    Liver Transpl; 2006 Jan; 12(1):12-5. PubMed ID: 16382452
    [No Abstract]   [Full Text] [Related]  

  • 20. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.